Vaniam Group shared a post on LinkedIn:
“A Message From Cherie Myatt:
As President of Vaniam Group, I’ve been thinking a lot about what it means to lead a company like this at this particular moment in oncology.
The science is moving faster than ever. The expectations on our clients have never been higher. And patients – real people navigating some of the hardest moments of their lives – are counting on all of us to get it right.
What excites me about Vaniam’s next chapter is that we’ve been quietly building for exactly this moment. Specialized teams with deep scientific credibility across the most complex therapeutic areas in medicine. Curio – our proprietary HCP engagement and insights platform – generating the kind of longitudinal oncology intelligence that informs decisions at every stage of a program.
And a Vaniam Intelligence Suite that puts that foundation to work in ways the industry hasn’t seen before. We’re not catching up. We’re already here.
My focus is simple: make sure everything we build next is worthy of the trust our clients, our people, and the patients we ultimately serve have placed in us.
There’s a lot to be excited about.”
Other articles about Vaniam Group on OncoDaily.